生物活性

• 描述Inolitazone is a high-affinity PPARγ agonist, which activates PPARγ with an EC50 about 1/50 that of rosiglitazone and has no effect on RIE cells that do not express PPARγ.
• 临床研究

• NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点
  NCT00408434	Neoplasm	Phase 1	Completed	-	United States, District of Col... more >>umbia Washington, District of Columbia, United States United States, Massachusetts Boston, Massachusetts, United States Collapse <<
  NCT00806286	Metastatic Non-small Cell Lung... more >> Cancer Collapse <<	Phase 2	Completed	-	-
  NCT00967616	Colorectal Cancer ... more >> Neoplasms, Colorectal Collapse <<	Phase 2	Completed	-	United States, California ... more >> Beverly Hills Cancer Center Beverly Hills, California, United States, 90211 St. Jude Heritage Medical Group Fullerton, California, United States, 92835 United States, District of Columbia John Marshall Washington, District of Columbia, United States, 20007 United States, Georgia Georgia Cancer Specialists Atlanta, Georgia, United States, 30341 United States, Maryland Victor Priego Bethesda, Maryland, United States, 20817 United States, Ohio Gabrail Cancer Center Canton, Ohio, United States, 44718 Argentina Instituto FIDES Oncologia y Especialidades Medicas Buenos Aires, Argentina, B1900BAJ CAIPO Centro para la Atencion Integral del Paciente Oncologico Tucuman, Argentina, T4000GTB Brazil Hospital Sao Lucas da Pontificia Universidade Catolica do Rio Grande do Sul - PUC-RS Porto Alegre, Brazil, 90610-000 Instituto Nacional de Cancer INCA Rio de Janeiro, Brazil, 20231-050 ICAVC Sao Paulo, Brazil, 01209-000 Chile Fundacion Arturo Lopez Perez Santiago, Chile, 8320000 Instituto Nacional del Cancer Santiago, Chile, 8380455 Instituto Oncologico Clinica Renaca Vina del Mar, Chile, 2540364 Peru Hospital Nacional Alberto Sabogai Sologuren Callao, Peru Hospital Nacional Dos de Mayo Lima, Peru, 01 Oncosalud SAC Lima, Peru, 41 Hospital Nacional Dos de Mayo Lima, Peru Collapse <<

• 更多